Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JUST: Smoking Cessation for Incarcerated Individuals
NCT03799315Completed
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Hennepin Healthcare Research Institute. Primary endpoint: Bioverified 7-day point prevalence abstinence from smoking at 3 weeks. Started Jan 2019; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03799315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799315.